Andrew N. Cornforth - Concepedia

Author

Andrew N. Cornforth

Also Known As

A N Cornforth, A. N. Cornforth, ANDREW N. CORNFORTH, Andrew Cornforth, Andrew N Cornforth, Andrew N. Cornforth, Andrew Nimitz Cornforth

Publications

787

Citations

H-Index

Concepts

All Affiliations

Hoag Memorial Hospital Presbyterian University of California, Irvine VA Long Beach Healthcare System University of California, Los Angeles University of California, Irvine Medical Center

About

Andrew N. Cornforth is an author at Hoag Memorial Hospital Presbyterian specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	388
2	Immunology	10	10	300
3	Cell Biology	8	8	310
4	Cellular Physiology	1	1	28
5	Cellular Therapies	1	1	107

Andrew N. Cornforth

Publications

685

Citations

H-Index

Page 1

	Year	Citations
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma Robert O. Dillman, Christopher Duma, Robin Ellis, Journal of Immunotherapy Cell TherapySurgical OncologyImmunologyImmunoeditingPathology	2009	107
FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells Andrew N. Cornforth, Jennifer S. Davis, Elham Khanifar, Oncogene Developmental BiologySignal TransductionSignaling PathwayAndrogen-dependent RegulationMedicine	2008	77
Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy Robert O. Dillman, Andrew N. Cornforth, Carol DePriest, Journal of Immunotherapy	2012	74
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses Robert O. Dillman, Andrew N. Cornforth, Gabriel I. Nistor, Journal for ImmunoTherapy of Cancer	2018	71
Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz, Cancer Biotherapy and Radiopharmaceuticals	2009	67
Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B‐positive patients with hepatocellular carcinoma Xiaojin Wang, Michael Bayer, Xiaosong Chen, Journal of Surgical Oncology	2015	34
Glioma Big Potassium Channel Expression in Human Cancers and Possible T Cell Epitopes for Their Immunotherapy Lisheng Ge, Neil Hoa, Andrew N. Cornforth, The Journal of Immunology T-regulatory CellImmunologyImmunotherapyCancer BiologyGlioma	2012	28
Glioma Cells Display Complex Cell Surface Topographies That Resist the Actions of Cytolytic Effector Lymphocytes Neil Hoa, Lisheng Ge, Yurii G. Kuznetsov, The Journal of Immunology ImmunologyImmunophenotypingImmunotherapeuticsComplex Surface TopographyImmunotherapy	2010	28
Characterization of Interferon-γ–Treated Melanoma Tumor Cells for Use in Dendritic Cell-Based Immunotherapy Andrew N. Cornforth, Abner Fowler, Denysha Carbonell, Cancer Biotherapy and Radiopharmaceuticals ImmunologyImmune RegulationImmunoeditingImmunotherapeuticsImmune Cell Therapy	2011	27
Durable Complete Response of Refractory, Progressing Metastatic Melanoma After Treatment with a Patient-Specific Vaccine Robert O. Dillman, Andreea A. Nanci, Scott Williams, Cancer Biotherapy and Radiopharmaceuticals Surgical OncologyImmunologyPathologyPatient-specific VaccineCervical Spine Metastases	2010	23

Page 1